Hematological immune related adverse events after treatment with immune checkpoint inhibitors-Reference-Cited by-同舟云学术

Hematological immune related adverse events after treatment with immune checkpoint inhibitors

Published:2021-04 Issue: Volume:147 Page:170-181
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Kramer Rafaela^ORCID,Zaremba Anne,Moreira Alvaro,Ugurel Selma,Johnson Douglas B.,Hassel Jessica C.^ORCID,Salzmann Martin^ORCID,Gesierich Anja,Weppler Alison^ORCID,Spain Lavinia,Loquai Carmen,Dudda Milena,Pföhler Claudia,Hepner Adriana^ORCID,Long Georgina V.,Menzies Alexander M.,Carlino Matteo S.,Sachse Michael M.,Lebbé Céleste,Baroudjian Barouyr,Enokida Tomohiro,Tahara Makoto,Schlaak Max,Hayani Kinan^ORCID,Bröckelmann Paul J.,Meier Friedegund,Reinhardt Lydia^ORCID,Friedlander Philip,Eigentler Thomas^ORCID,Kähler Katharina C.,Berking Carola,Zimmer Lisa^ORCID,Heinzerling Lucie

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference47 articles.

1. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;N Engl J Med,2010

2. Immunostimulatory monoclonal antibodies for cancer therapy;Melero;Nat Rev Canc,2007

3. Immune checkpoint blockade therapy for cancer: an overview of FDA-approved immune checkpoint inhibitors;Hargadon;Int Immunopharmacol,2018

4. Adjuvant pembrolizumab versus Placebo in resected stage III melanoma;Eggermont;N Engl J Med,2018

5. Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma;Amaria;Nat Med,2018

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hémophilie acquise : quoi de neuf en 2024 ?;La Revue de Médecine Interne;2024-09

2. Biomarkers associated with immune-related adverse events induced by immune checkpoint inhibitors;World Journal of Clinical Oncology;2024-08-24

3. Influence of the Immune Checkpoint Inhibitors on the Hemostatic Potential of Blood Plasma;Transfusion Medicine and Hemotherapy;2024-08-21

4. Efficacy and challenges of anti-PD1 in MSI-H mCRC: a case report on concurrent infections and ir-AIHA;Frontiers in Oncology;2024-08-13

5. A Case of Immune Aplastic Anemia during Combined Treatment with Atezolizumab and Chemotherapy for Non-Small Cell Lung Cancer;Journal of Nippon Medical School;2024-06-25